mayo school of continuous professional development case-based
Post on 03-Feb-2022
1 Views
Preview:
TRANSCRIPT
$75 DISCOUNTIF YOU REGISTER
ON OR BEFORE JAN 10, 2019
CE.MAYO.EDU/HEMONC2019
OMNI SCOTTSDALE RESORT & SPA AT MONTELUCIASCOTTSDALE, ARIZONAFEBRUARY 15–17, 2019
Mayo Clinic School of Continuous Professional Development
Alan H. Bryce, M.D. Rafael Fonseca, M.D.
COURSE HIGHLIGHTS• Comprehensive update and management strategies for key hematologic and
oncologic diseases
• New data and best practices for practicing physicians and the entire healthcare team
• Half-day symposium on CAR-T therapy
• Case and panel discussions
• Renowned guest and Mayo Clinic faculty
• Continuing education credit offered for physicians, pharmacists and nurses
LEARNING OBJECTIVESUpon conclusion of this program, participants should be able to:
• Describe the appropriate patient population for CAR-T therapy.
• Select appropriate patients for neoadjuvant therapy for breast cancer.
• Relate diagnostic criteria for smoldering and active myeloma, including revised International Myeloma Working Group guidelines.
• List donor sources available for allogeneic stem cell transplantation.
• Review the latest developments in cellular therapy applied to cancer.
• State the role of immune checkpoint blockade in the treatment of bladder cancer.
• Identify two strategies for incorporating Cancer Survivorship Care Plans into clinical practice.
• Recall state-of-the-art data applicable to management of early stage HER2+ breast cancer (neoadjuvant and adjuvant).
• Recognize the role of pathology and nuclear medicine imaging in making treatment decisions for patients with neuroendocrine tumors.
TARGET AUDIENCEThis course is designed for physicians practicing in hematology and oncology, as well as physician assistants, nurse practitioners, nurses, pharmacists, and other healthcare professionals interested in the diagnosis and treatment of patients with hematologic and oncologic disorders.
REGISTRATION
COURSE DIRECTORS
Registration Fee On/Before Jan 10, 2019 After Jan 10, 2019
Physicians/Scientists $600 USD $675 USD
Fellows, Residents, Physician Assistants, Nurse Practitioners, Nurses, Pharmacists
$400 USD
$475 USD
Please visit ce.mayo.edu/cancellation for more information.
CE.MAYO.EDU/HEMONC2019
LODGING & ACCOMMODATIONS Omni Scottsdale Resort & Spa at Montelucia 4949 East Lincoln Drive | Scottsdale, Arizona 85253 | Telephone: (888) 627-3010 Reservations: www.omnihotels.com/hotels/scottsdale-montelucia/meetings/HEMONC2019
A special group rate of $299 (USD), per room per night, plus applicable city/state sales tax, single or double occupancy, is available for course participants and guests.
A reduced resort fee of $10, per room, per night, includes basic guestroom wireless internet, local and toll free calls, access to the fitness center, Kasbah and Oasis Pools, in-room coffee and tea, and USA Today newspaper, upon request. Self-parking is complimentary. Group rates apply three days prior to and three days post-course dates, based upon availability.
To ensure accommodations, make your reservation before the room block fills or by January 14, 2019, via website or telephone, and reference “Mayo Clinic Hematology & Oncology.”
Attendees are responsible for their own reservations. The standard hotel reservation cancellation policy will apply to individual reservations unless otherwise specified.
Mayo School of CPD is not responsible for expenses incurred by an individual who is not confirmed and for whom space is not available at the meeting. Costs incurred by the registrant such as airline or hotel fees or penalties are the responsibility of the registrant.
TRAVEL Hertz is offering a reduced daily rate for participants attending the course. Visit Hertz, www.hertz.com, and enter CV03NR0014 in the respective “discount or promo code” section. Special rates include unlimited mileage and are subject to availability. Advance reservations are recommended as cars are subject to availability; blackout dates may apply.
SuperShuttle vans offer airport transportation to and from area hotels and businesses. To make reservations, visit www.supershuttle.com or call (800) 258-3826 or (602) 244-9000.
RECREATIONAL ACTIVITIES Visit www.experiencescottsdale.com or www.visitphoenix.com for leisure activities.
CE.MAYO.EDU/HEMONC2019PROGRAM AT-A-GLANCEA complete program schedule is on the website:
FRIDAY, FEBRUARY 15, 2019
MYELOMAManagement of Newly Diagnosed Multiple Myeloma Including Stem Cell TransplantationBenefits of Maintenance Therapy and the Treatment of the First Relapse: A Second ChanceSubsequent Relapse
MYELOID DISORDERSMDS / MPN Overlap SyndromesAllogeneic BMT: Who to Refer and Donor SelectionUpdate on Myelodysplastic Syndromes
NON-HODGKINS LYMPHOMAPrimary Central Nervous System Lymphoma: Update 2019Update on Diffuse Large B Cell Lymphoma TherapyMantle Cell Lymphoma Update
BENIGN HEMATOLOGY / CHRONIC LYMPHOCYTIC LEUKEMIAThromboembolism Management and ThrombocytopeniaDirect Oral Anticoagulants: Guidelines for Clinical PracticeHow Do I Assess My CLL Patients’ Risk for Progression and What is My Best Choice for Upfront Therapy in 2019?
SATURDAY, FEBRUARY 16, 2019
CAR-T CELL THERAPYFrom Model T to Tesla: A Brief History of CARs for LymphomaUpdates on CAR-T Cell Therapy in LymphomaCARs and More: How Fast Are They Moving?Myeloma CAR-T TherapyThe Future of CAR-T Cells Panel Discussion
SOLID TUMORSUpdate on Diagnosis and Treatment of GliomaNeoadjuvant and Adjuvant Therapy for Lung CancerUpdate in the Management of Metastatic Lung CancerIntegrating New Therapeutics into Bladder Cancer TreatmentSequencing Therapies in Metastatic Kidney CancerCardio-Oncology: A Multidisciplinary Approach to Managing Cardiovascular Complications in Cancer PatientsIncorporating Cancer Survivorship Care Plans into a Busy Clinical Practice: Meeting Clinical Guidelines and Addressing Patient Need
SUNDAY, FEBRUARY 17, 2019
SOLID TUMORSNovel Approaches to HER2+ and Triple Negative Breast CancersAdjuvant Management of Hormone Receptor Positive Breast CancerFamilial Cancer Syndromes: An Under-Diagnosed ProblemHepatobiliary CancerAdvances in the Diagnosis and Management of Neuroendocrine TumorsClinical Updates in the Treatment of Advanced Colorectal and Gastro-Esophageal Cancers
CREDIT In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
AMA: Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 20.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACPE: Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 18.0 ACPE Knowledge-based contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity. Participants must complete the entire activity and are required to complete an online evaluation(s) to earn credit.
Visit the activity’s website for additional information regarding the ACPE credit offering.
AAFP: Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.
ANCC: Participants can earn up to 20.0 ANCC nursing contact hours commensurate with the extent of their participation in the activity. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals: A certificate of attendance will be provided to other healthcare professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.
FACULTYCourse Directors
Alan H. Bryce, M.D. Rafael Fonseca, M.D.
Guest Faculty
Jeremy S. Abramson, M.D. Assistant Professor of Medicine
Harvard Medical School Clinical Director, Lymphoma Program Dana-Farber / Harvard Cancer Center
Massachusetts General Hospital Boston, Massachusetts
Patrick Forde, M.B.B.Ch. Assistant Professor of Oncology
Johns Hopkins University School of Medicine Baltimore, Maryland
Guillermo Garcia-Manero, M.D. Professor
Deputy Chair, Translational Research Chief, Section of Myelodysplastic Syndromes
Department of Leukemia, Division of Cancer Medicine The University of Texas MD Anderson Cancer Center
Houston, Texas
Jonathan E. Rosenberg, M.D. Chief, Genitourinary Medical Oncology
Division of Solid Tumor Oncology Memorial Sloan Kettering Cancer Center
New York, New York
Mayo Clinic Faculty
Sikander Ailawadhi, M.D.
Noel M. Arring, D.N.P., R.N., O.C.N.
Tanios S. Bekaii-Saab, M.D.
Mitesh J. Borad, M.D.
Alan H. Bryce, M.D.
Januario Castro, M.D.
Rafael Fonseca, M.D.
Thorvardur R. Halfdanarson, M.D.
Thai H. Ho, M.D., Ph.D.
Neil E. Kay, M.D.
Yi Lin, M.D., Ph.D.
Farouk Mookadam, M.B., B.Ch.
Donald W. Northfelt, M.D.
Brian Patrick O’Neill, M.D.
Leslie J. Padrnos, M.D.
Harshita R. Paripati, M.D.
Mrinal Patnaik, M.B.B.S.
Edith A. Perez, M.D.
Alyx Porter, M.D.
Allison C. Rosenthal, D.O.
Niloy Jewel Samadder, M.D.
Lisa Z. Sproat, M.D.
Keith Stewart, M.B., Ch.B.
Prakash Vishnu, M.B.B.S.
Thomas E. Witzig, M.D.
MA
YO
CL
INIC
1340
0 E
ast S
hea
Bou
leva
rdS
cott
sdal
e, A
rizon
a 85
259
Em
ail:
mca
.cm
e@m
ayo.
edu
Ph
on
e: (4
80) 3
01-4
580
©20
18 M
ayo
Foun
dat
ion
for
Med
ical
Ed
ucat
ion
and
Res
earc
h |
MC
8300
-54
May
o C
linic
Sch
ool o
f Con
tinuo
us P
rofe
ssio
nal D
evel
opm
ent u
ses
mul
tiple
mai
ling
lists
and
can
not a
lway
s el
imin
ate
dup
licat
ions
. If y
ou h
ave
rece
ived
mul
tiple
bro
chur
es, p
leas
e p
ost o
r sh
are
them
with
inte
rest
ed c
olle
ague
s.
$75
DISC
OUNT
FOR
EAR
LY R
EGIS
TRAT
ION
(offe
r ex
pire
s Ja
nuar
y 10
, 201
9)
CE.M
AYO.
EDU/
HEM
ONC2
019
OMNI
SCO
TTSD
ALE
RESO
RT &
SPA
AT
MON
TELU
CIA
SCOT
TSDA
LE, A
RIZO
NAFE
BRUA
RY 1
5–17
, 201
9
top related